Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals presents its late‑stage CNS and cardiometabolic candidates at the 9th Annual Neuroscience Innovation Forum, boosting investor visibility and highlighting its in‑house drug discovery pipeline.

Reviva Pharmaceuticals, a Nasdaq‑listed biopharma, is advancing innovative CNS, cardiovascular, metabolic, and inflammatory therapies amid volatile stock swings and strong R&D focus.

Reviva Pharmaceuticals Holdings, Inc. is a clinical development pharmaceutical company focused on addressing unmet medical needs in various therapeutic areas, with a global presence and a mission to develop transformative therapies.

Reviva Pharmaceuticals Holdings Inc. is a clinical development pharmaceutical company focused on developing innovative therapies for unmet medical needs, with a mission to bring hope and healing to patients worldwide.

Reviva Pharmaceuticals Holdings Inc. is navigating a challenging period in the stock market, but remains committed to developing therapies for unmet medical needs.